• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

评估胆淤积症妊娠不良产科结局的生化标志物的预测价值。

Evaluation of predictive value of biochemical markers for adverse obstetrics outcomes in pregnancies complicated by cholestasis.

机构信息

Gynaecological and Obstetrical University Hospital in Poznan, Poland.

Department of Reproduction, Chair of Obstetrics, Gynaecology, and Gynaecological Oncology, Poznan University of Medical Sciences, Poland.

出版信息

Ginekol Pol. 2020;91(5):269-276. doi: 10.5603/GP.2020.0051.

DOI:10.5603/GP.2020.0051
PMID:32495933
Abstract

OBJECTIVES

Intrahepatic cholestasis of pregnancy (ICP) is significantly more often associated with an abnormal perinatal outcome compared to a group of healthy pregnant women. The aim of the study was to analyse the correlation between the adverse perinatal outcome and the biochemical parameters in pregnancy complicated by cholestasis, and to assess their predictive value for neonatal complications.

MATERIAL AND METHODS

Eighty-six patients with ICP were divided into 3 groups according to their fasting serum bile acid level [group I n = 60, 10-39.90 μmol/L; group II n = 20, 40-99.90 μmol /L; group III n = 6, TBA (total bile acids) ≥ 100.00 μmol/L]. Linear regression models were created to determine the relation of serum TBA, ALT, and AST concentration with total adverse perinatal outcome, defined as an occurrence of at least one perinatal outcome: stillbirth, preterm birth, spontaneous and iatrogenic preterm birth, presence of meconium in amniotic fluid, Apgar score (< 7 in 5th min), pH from umbilical artery (< 7.1), necessity for NICU admission, the presence of breathing disorders, and the need to perform phototherapy.

RESULTS

TBA ≥ 40.00 μmol/L is connected to an elevated risk of the occurrence of total adverse perinatal outcome (OR = 4.17, p = 0.0037, AUC = 0.62, p = 0.046). TBA ≥ 40.00 μmol/L is a predictor of preterm birth (OR 2.3, p = 0.0117), iatrogenic preterm birth (OR 2.5, p = 0.006), admission to NICU (OR 2.38, p = 0.0094), intubation or assisted ventilation (OR 2.16, p = 0.0301), and phototherapy (OR 2.0, p = 0.0438). The threshold value of TBA for the need for phototherapy was 52.7 μmol/L (AUC = 0.67, p = 0.0089) and for preterm birth, 32.1 μmol/L (AUC = 0.62, p = 0.0251).

CONCLUSIONS

Pregnant women with ICP and TBA serum level over 40.00 μmol/L have a worse prognosis regarding obstetric outcomes. The concentration of bile acids is a predictor of the occurrence of adverse perinatal outcomes, although the concentration of ALT and AST failed to show such a connection.

摘要

目的

与健康孕妇相比,妊娠肝内胆汁淤积症(ICP)显著更常与不良围产结局相关。本研究的目的是分析胆汁淤积性妊娠中不良围产结局与生化参数之间的相关性,并评估其对新生儿并发症的预测价值。

材料与方法

86 例 ICP 患者根据空腹血清胆汁酸水平分为 3 组[组 I n = 60,10-39.90 μmol/L;组 II n = 20,40-99.90 μmol/L;组 III n = 6,TBA(总胆汁酸)≥100.00 μmol/L]。建立线性回归模型以确定血清 TBA、ALT 和 AST 浓度与总不良围产结局的关系,总不良围产结局定义为至少发生一种围产结局:死胎、早产、自发性和医源性早产、羊水胎粪污染、Apgar 评分(第 5 分钟 < 7)、脐动脉 pH 值(<7.1)、需要入住 NICU、存在呼吸障碍和需要进行光疗。

结果

TBA≥40.00 μmol/L 与总不良围产结局的发生风险升高相关(OR = 4.17,p = 0.0037,AUC = 0.62,p = 0.046)。TBA≥40.00 μmol/L 是早产(OR 2.3,p = 0.0117)、医源性早产(OR 2.5,p = 0.006)、入住 NICU(OR 2.38,p = 0.0094)、插管或辅助通气(OR 2.16,p = 0.0301)和光疗(OR 2.0,p = 0.0438)的预测因素。需要光疗的 TBA 阈值为 52.7 μmol/L(AUC = 0.67,p = 0.0089),早产的 TBA 阈值为 32.1 μmol/L(AUC = 0.62,p = 0.0251)。

结论

血清 TBA 水平超过 40.00 μmol/L 的 ICP 孕妇的产科结局更差。胆汁酸浓度是不良围产结局发生的预测因素,尽管 ALT 和 AST 浓度未能显示出这种关联。

相似文献

1
Evaluation of predictive value of biochemical markers for adverse obstetrics outcomes in pregnancies complicated by cholestasis.评估胆淤积症妊娠不良产科结局的生化标志物的预测价值。
Ginekol Pol. 2020;91(5):269-276. doi: 10.5603/GP.2020.0051.
2
The concentrations of bile acids and erythropoietin in pregnant women with intrahepatic cholestasis and the state of the fetus and newborn.妊娠肝内胆汁淤积症孕妇的胆汁酸和促红细胞生成素浓度以及胎儿和新生儿的状况
Med Wieku Rozwoj. 2013 Jul-Sep;17(3):232-45.
3
Association of adverse perinatal outcomes of intrahepatic cholestasis of pregnancy with biochemical markers: results of aggregate and individual patient data meta-analyses.妊娠肝内胆汁淤积症不良围产结局与生化标志物的关联:汇总和个体患者数据荟萃分析结果。
Lancet. 2019 Mar 2;393(10174):899-909. doi: 10.1016/S0140-6736(18)31877-4. Epub 2019 Feb 14.
4
Role of postprandial bile acids in prediction of perinatal outcome in intrahepatic cholestasis of pregnancy.餐后胆汁酸在预测妊娠肝内胆汁淤积症围产期结局中的作用
J Obstet Gynaecol Res. 2014 Jul;40(7):1883-9. doi: 10.1111/jog.12444.
5
Predictors of adverse neonatal outcomes in intrahepatic cholestasis of pregnancy.妊娠肝内胆汁淤积症不良新生儿结局的预测因素
Am J Obstet Gynecol. 2015 Oct;213(4):570.e1-8. doi: 10.1016/j.ajog.2015.06.021. Epub 2015 Jun 10.
6
Intrahepatic cholestasis of pregnancy: biochemical predictors of adverse perinatal outcomes.妊娠期肝内胆汁淤积症:围产期不良结局的生化预测指标
J Huazhong Univ Sci Technolog Med Sci. 2013 Jun;33(3):412-417. doi: 10.1007/s11596-013-1133-8. Epub 2013 Jun 17.
7
Re-evaluating diagnostic thresholds for intrahepatic cholestasis of pregnancy: case-control and cohort study.重新评估妊娠肝内胆汁淤积症的诊断阈值:病例对照和队列研究。
BJOG. 2021 Sep;128(10):1635-1644. doi: 10.1111/1471-0528.16669. Epub 2021 Apr 6.
8
Bile acid levels and risk of adverse perinatal outcomes in intrahepatic cholestasis of pregnancy: A meta-analysis.胆汁酸水平与妊娠期肝内胆汁淤积症围产期不良结局风险的Meta分析
J Obstet Gynaecol Res. 2017 Sep;43(9):1411-1420. doi: 10.1111/jog.13399. Epub 2017 Jul 10.
9
Perinatal death by bile acid levels in intrahepatic cholestasis of pregnancy: a systematic review.妊娠期肝内胆汁淤积症胆汁酸水平与围产儿死亡:系统评价。
J Matern Fetal Neonatal Med. 2021 Nov;34(21):3614-3622. doi: 10.1080/14767058.2019.1685965. Epub 2019 Nov 19.
10
Correlation of bile acids and aspartate-aminotransferase with outcomes in cholestasis of pregnancy.胆汁酸和天门冬氨酸转氨酶与妊娠肝内胆汁淤积症结局的相关性。
J Neonatal Perinatal Med. 2020;13(4):513-519. doi: 10.3233/NPM-190276.

引用本文的文献

1
A Rare Variant in a Familial Case of Intrahepatic Cholestasis of Pregnancy: A Potential Novel Genetic Contributor.一例妊娠肝内胆汁淤积症家族病例中的罕见变异:一种潜在的新型遗传因素
J Clin Med. 2025 Aug 8;14(16):5618. doi: 10.3390/jcm14165618.
2
The severity of intrahepatic cholestasis during pregnancy increases risks of adverse outcomes beyond stillbirth: evidence from 15,826 patients.妊娠期肝内胆汁淤积症的严重程度增加了不良结局的风险,超出了胎儿死亡:来自 15826 名患者的证据。
BMC Pregnancy Childbirth. 2024 Jul 12;24(1):476. doi: 10.1186/s12884-024-06645-2.
3
Serum placental growth factor, total cholesterol, and triglycerides for prediction of intrahepatic cholestasis of pregnancy.
血清胎盘生长因子、总胆固醇和甘油三酯预测妊娠肝内胆汁淤积症。
Medicine (Baltimore). 2023 Dec 15;102(50):e36178. doi: 10.1097/MD.0000000000036178.
4
Risk Scoring Systems for Preterm Birth and Their Performance: A Systematic Review.早产风险评分系统及其性能:一项系统综述。
J Clin Med. 2023 Jun 28;12(13):4360. doi: 10.3390/jcm12134360.
5
The association of serum total bile acid with new-onset hypertension during pregnancy.血清总胆汁酸与妊娠期新发高血压的关系。
BMC Pregnancy Childbirth. 2022 Nov 26;22(1):879. doi: 10.1186/s12884-022-05211-y.
6
Predictive and Diagnostic Value of Serum Adipokines in Pregnant Women with Intrahepatic Cholestasis.血清脂肪因子在妊娠肝内胆汁淤积症患者中的预测和诊断价值。
Int J Environ Res Public Health. 2022 Feb 16;19(4):2254. doi: 10.3390/ijerph19042254.
7
Management of Intrahepatic Cholestasis of Pregnancy: Recommendations of the Working Group on Obstetrics and Prenatal Medicine - Section on Maternal Disorders.妊娠期肝内胆汁淤积症的管理:产科学与产前医学工作组-母体疾病分会的建议
Geburtshilfe Frauenheilkd. 2021 Aug;81(8):922-939. doi: 10.1055/a-1386-3912. Epub 2021 Aug 9.